The United States Patent and Trademark Office has issued a patent to EyeGate Pharmaceuticals for its iontophoretic contact lens, the company announced in a press release.
The patent, the first covering the iontophoretic contact lens, is for a multi-layer contact lens for ocular therapy. It has a reservoir with an electrically charged therapeutic compound and an electrode that provides an iontophoretic current to the charged compound to propel it into ocular tissue, the release said.
“We believe this technology, which could enable at-home administration of iontophoretic drugs, has the
Uncategorized